Translate
Xencor Inc
About
Xencor Inc (NASDAQ:XNCR) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 4 2026
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast
Feb 25 2026
Xencor Reports Fourth Quarter and Full Year 2025 Financial Results
Jan 8 2026
Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones
Dec 9 2025
Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies
Nov 10 2025
Xencor to Participate at Upcoming Investor Conferences
Financials
Revenue
$125.58 M
Market Cap
$939.47 M
EPS
-1.24